BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Phenobarbital
,
rs2300478
,
IL1A
,
Leukemia
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phenylpropanolamine
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Systemic hypertension and hypertensive retinopathy following PPA overdose in a dog.
Separation of enantiomers of norephedrine by capillary electrophoresis using cyclodextrins as chiral…
The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increa…
Urodynamic and haemodynamic effects of a single oral administration of ephedrine or phenylpropanolam…
Posterior reversible encephalopathy syndrome complicating intracranial hemorrhage after phenylpropan…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmacologic Intervention for Postcessation Weight Gain
European Trial of Pirfenidone in BOS, A European Multi-center Study
Myocardial Infarction and Non-contraceptive Estrogen Use
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
Determination of the Optimal Dose of Ephedrine in Intraoperative Arterial Hypotension of Newborns an…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ